Description
LIQUID GLASSIA - NDC - 00944-2884-01
First action · last action
2017-02-27 · 2017-08-09
Transactions
2
First transaction's obligation
$104,000
Base + all options value (sum of deltas)
$105,560
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA25017A0009
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-02-27+$104,000= $104,000
- Mod P000012017-08-09+$1,560= $105,560
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-02-27 | +$104,000 | $104,000 | LIQUID GLASSIA - NDC - 00944-2884-01 |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2017-08-09 | +$1,560 | $105,560 | LIQUID GLASSIA - NDC - 00944-2884-01 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI LT5GEHL2F1K6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25921F0372 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $26,600 | FY2021 |
| 36C26321N0774 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $10,521 | FY2021 |
| 36C25921F0339 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $13,300 | FY2021 |
| 36C25921F0331 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $21,830 | FY2021 |
| 36C25921F0283 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $21,830 | FY2021 |
| 36C26121P0490 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $23,040 | FY2021 |
Other recipients under 6505 from 506-ANN ARBOR (00506) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25018F1916 | ALEXION PHARMACEUTICALS INC | 506-ANN ARBOR (00506) | $19,612 | FY2018 |
| 36C25018N1847 | PFIZER INC | 506-ANN ARBOR (00506) | $16,483 | FY2018 |
| 36C25018P1066 | ACCREDO HEALTH GROUP, INC | 506-ANN ARBOR (00506) | $16,292 | FY2018 |
| 36C25018N1060 | PFIZER INC | 506-ANN ARBOR (00506) | $16,483 | FY2018 |
| 36C25018F0432 | JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. | 506-ANN ARBOR (00506) | $10,819 | FY2018 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25017J2113_3600_VA25017A0009_3600 · retrieved 2026-09-26.